Associated Papers
Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG.
Iyer S et al.
Disease Models & Mechanisms, 2019
Select a paper to view details
Iyer S et al.
Disease Models & Mechanisms, 2019